key: cord-0797636-ug7hi2jc authors: Santos, Gabriela F.; Portela, João; Argyropoulou, Despoina; Varudo, Rita; Pimenta, Inês; Oliveira, Ana; Lança, Sara; Fernandes, Antero title: Alveolar Proteinosis Due to Toxic Inhalation at Workplace date: 2020-08-26 journal: Respir Med Case Rep DOI: 10.1016/j.rmcr.2020.101199 sha: 57953723373d6ef4bfe73f1bc47c0ab66bc872fc doc_id: 797636 cord_uid: ug7hi2jc We report a clinical case of a 39-year old male, without any known previous medical condition but with occupational exposure to paints and dust cement, who presented an autoimmune pulmonary alveolar proteinosis (PAP) triggered by exposure to toxic inhalation at his workplace. PAP is a rare lung disease characterized by intra-alveolar abnormal accumulation of surfactant. The presence of a crazy-paving pattern in high-resolution computed tomography scan brings the suspicion of PAP although histopathology results of bronchoalveolar lavage are always required for its final diagnosis. The autoimmune form of PAP due to toxic inhalation, such as the one here described, is rare and it is usually difficult to establish a causal relationship. Pulmonary alveolar proteinosis (PAP) is a rare lung disease, first described as a distinct clinical entity in 1958 1 . Its incidence is estimated to be 0.2-0.4 cases per million [2] [3] [4] , with a male predisposition (2:1 to 3:1, male:female) 2, 5 . Approximately 72% of patients are active smokers 2 . PAP is a surfactant-like disease characterized by intra-alveolar abnormal accumulation of surfactant. The complex surfactant homeostasis is disturbed in PAP 2,6,7 , which can occur through different mechanisms, namely disruption of granulocyte-macrophage colony stimulating factor (GM-CSF) signaling (primary PAP), alveolar macrophages dysfunction (secondary PAP) or surfactant production disorders (congenital PAP) 3,5,8,9 . Autoimmune (aPAP) and secondary PAP (sPAP), occur typically in adulthood 3, 5 and have similar clinical presentation 3 . Congenital PAP occurs in neonatal period causing acute respiratory distress (discussed somewhere else). The majority of cases are aPAP (approximately 90%) compared to sPAP which are only present in 4% of the cases 7, 10 . The aPAP patients are slightly older, at the time of diagnosis, when compared to sPAP (between 39 to 51 years instead of 37 to 45 years, respectively) 11 . An aPAP is mediated by the formation of immunoglobulin G (IgG) auto-antibodies that block GM-CSF 12 , whilst sPAP is associated with the presence of other conditions or co-morbidities, like infection, toxic inhalation, malignancy and immunodeficiency, without the formation of GM-CSF auto-antibodies 3,8,9 . Patients usually present a progressive exertional dyspnea of insidious onset associated with cough, tiredness, malaise or low grade fever. Hypoxemic respiratory failure is the major clinical finding 3 , secondary to a right to left shunting effect of blood from an intact pulmonary capillary bed perfusing through poorly ventilated alveoli 13 . Unrecognizing this condition, especially if extensive disease is present, leads to progressive refractory hypoxemia and development of acute respiratory distress. Physical examination is usually normal with unspecific inspiratory crackles at pulmonary auscultation 2, 5, 13 . Differential diagnosis can be broad, like opportunistic diseases (e.g. pneumocystosis), pulmonary oedema, exogenous lipoid pneumonia, acute eosinophilic pneumonia, acute interstitial pneumonia, sarcoidosis, alveolar haemorrhage, invasive lepidic mucinous adenocarcinoma and drug-induced lung diseases. High-resolution computed tomography (HRCT) scan can be a helpful tool 14 , J o u r n a l P r e -p r o o f showing ground-glass opacities combined with thickened polygonal septal lines and intralobular reticulations, predominantly in the lower lobes 15, 16 , resembling a cobblestone appearance, also known as a "crazy paving" pattern. This pattern is typical in PAP but unspecific and therefore not pathognomonic 14, 16 . More rarely, PAP can also present an interstitial, focal, nodular or even fibrotic pattern 5, 14 . BAL is useful to identify the presence of PAP 3,17,18 . We report a case of a 39-year-old Caucasian male with a 30 pack-year cigarette smoker, who denies other types of smoking. He has no relevant medical history and does not take any medication. He works as a maintenance worker, exposed to paints, sprays and cement dust. He has two cats at home. No medication allergies are known or other type of allergies. Since November 2019 he started to complain of dyspnea, on exertion only (mMRC 1 - . Three months later he started to refer progressive worsening of dyspnea (mMRC 3-4) associated with flu-like symptoms (dry cough and malaise). He denied having fever, night sweats or chills, hemoptysis, weight loss, anorexia, rashes, arthralgias or myalgias, recent travelling or injuries or sick contacts. He was first observed by his general practitioner and did a chest X-ray that revealed a diffuse bilateral heterogeneous alveolar infiltrate in the lower and middle lobes. He was started on antibiotic -amoxicillin 500mg -without any clinical improvements, which lead him to the emergency department. On physical examination, he presented dyspnea at rest and hypoxemic respiratory failure, with the following vital signs: blood pressure 153/83mmHg, pulse rate 84 beats/min and oxygen saturation of Human immunodeficiency virus; ACE -Angiotensin-converting enzyme; SVsedimentation velocity; Hb -hemoglobina. Diagnosing PAP is challenging. Clinical history and demographic features of our patient combined with lifestyle behaviors (active smoker), occupational exposure and the presence of a "crazy paving" pattern in HRCT scan - Figure 1 -enhanced the suspicion for a PAP diagnosis 6, 19 . However, exclusion of other diseases was needed in order to consider PAP's diagnosis. For that, serological and microbiology testing, in the serum and in the BAL, were performed. Some serological markers such as an elevated LDH, which is observed in 80% of PAP patients, and polycythemia, were present although these are unspecific 20 . Macroscopically, BAL had a milky appearance - alveoli with noncellular, finely granular and eosinophilic material which represents lipoproteinaceous alveolar accumulation 9 . Pneumocystis jirovecci pneumonia and pulmonary oedema were both excluded as they stained negative for PAS. Pulmonary oedema lacks the coarse granules seen in PAP thru PAS staining; Grocott-Gomori methenamine silver staining was negative for Pneumocystis jirovecci 22 . Other infectious were excluded (Table 1) , with the only exception for HCNL63. Histopathological findings from BAL made the final diagnosis of PAP 3,17,18 . Further investigations were performed to determine the nature of PAP. Immunodeficiencies, hematologic disorders or major toxic disorders were not detected. High titers of auto-antibodies (IgG) against GM-CSF were detected in the serum of our patient, when compared to positive controls (in serial dilutions -1/50; 1/250; 1/1000), reported to us by an outside laboratory (INSERM UMR 1163, see acknowledgments). Upon these results we consider to be in the presence of aPAP 7,12 that was triggered by cement dust and paints exposure. As previously reported, occupational exposures are important risk factors for development of autoimmune diseases 23 . Some cohort PAP studies have reported positive GM-CSF auto-antibodies from toxic inhalation 4, 24, 25 suggesting that an unknown autoimmune disease could be triggered by it, like an aPAP 25, 26 . Pulmonary Alveolar Proteinosis State of the Art: Pulmonary Alveolar Proteinosis, Progress in the First 44 Years Pulmonary alveolar proteinosis Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan Rare lung diseases II : Pulmonary alveolar proteinosis (Review) Pulmonary alveolar proteinosis Pulmonary Alveolar Proteinosis Pulmonary Alveolar Proteinosis Management: Current and Future Therapeutic Strategies Pulmonary alveolar proteinosis Assessment and management of pulmonary alveolar proteinosis in a reference center Secondary pulmonary alveolar proteinosis: a singlecenter retrospective study (a case series and literature review) Granulocyte/macrophage -colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects Pulmonary alveolar proteinosis : clinical aspects and current concepts on pathogenesis CT Features of Pulmonary Alveolar Proteinosis Crazy-Paving" Pattern at Thin-Section CT of the Lungs: Radiologic-Pathologic Overview The crazy-paving pattern : a radiologicalpathological correlation Pulmonary Alveolar Proteinosis: A Spectrum of Cytologic, Histochemical, and Ultrastructural Findings in Bronchoalveolar Lavage Fluid The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease Crazy Paving in Pulmonary Alveolar Proteinosis Whole lung lavage -Report of four cases of alveolar proteinosis Pulmonary Alveolar Proteinosis and mimics Alveolar Proteinosis Occupational exposures and autoimmune diseases Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients Pulmonary Alveolar Proteinosis Associated with Dust Inhalation Not Secondary but Autoimmune ? The Role of Anti-GM-CSF Antibodies Understanding Human Coronavirus HCoV-NL63 GM-CSF modulates pulmonary resistance to influenza A infection Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis : A Multicenter International Study of GELF Whole lung lavage -technical details , challenges and management of complications Valuable Serum Markers in Pulmonary Alveolar Proteinosis Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocytemacrophage colony-stimulating factor: a meta-analyses Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases Inhaled Granulocyte/ Macrophage-Colony Stimulating Factor as Therapy for Pulmonary Alveolar Proteinosis J o u r n a l P r e -p r o o f x The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f